Notice the limitation immediately
There can be medical complications like gastroparesis (lack of stomach emptying) and pancreatitis (inflammation of the pancreas)
In the SURPASS-2 trial, patients with obesity and T2D who received tirzeapatide (5 mg weekly) achieved greater HbA1c and body weight reductions than those receiving semaglutide (1 mg weekly) during the 40 week study (64) despite comparable putative GLP-1R occupancy at these doses (47)
It is a more potent anticancer and anti-inflammatory agent than RES (Chiou et al., 2011) and it distributes widely among the main target organs (brain, liver, kidney, heart and lung) for what seems to be a promising (Choo et al., 2014) and safe (Riche et al., 2013) therapeutic strategy
Certain health conditions, physiological states, or expectations may increase risk or limit safety
To ensure you get the most effective results, it is essential to take your injection on the same day each week